Your browser doesn't support javascript.
Increasing demand for point-of-care testing and the potential to incorporate the Internet of medical things in an integrated health management system.
Karako, Kenji; Song, Peipei; Chen, Yu; Tang, Wei.
  • Karako K; Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Song P; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Chen Y; Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Tang W; International Health Care Center, National Center for Global Health and Medicine, Tokyo, Japan.
Biosci Trends ; 16(1): 4-6, 2022 Mar 11.
Article in English | MEDLINE | ID: covidwho-1705129
ABSTRACT
As the number of people with COVID-19 increases daily around the world, point-of-care testing (POCT) is gaining attention as a tool that can provide immediate test results and greatly help to deter infection and determine what to do next. POCT has several drawbacks such as a low sensitivity and specificity, but according to studies POCT has increased sensitivity on par with that of polymerase chain reaction testing. The advantage of POCT is that the results can be obtained quickly, regardless of the location. To further enhance its benefits, POCT is being developed and researched in conjunction with the Internet of medical things (IoMT), which allows POCT results to be collected, recorded, and managed over a network. IoMT will be beneficial not only for the use of POCT simply as a testing tool but also for its integration into diagnostic and health management systems. IoMT will enable people to regularly receive their test results in their daily lives and to provide personalized diagnosis and treatment of individual conditions, which will be beneficial in terms of disease prevention and maintenance of health.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Biosci Trends Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: Bst.2022.01074

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Biosci Trends Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: Bst.2022.01074